These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6759457)

  • 1. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque.
    Smith HJ; Corbett DB; Loeb PM; Peterson WL
    Invest Radiol; 1982; 17(6):629-33. PubMed ID: 6759457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyropanoate cholecystography early in the course of acute pancreatitis.
    Longstreth GF; Slivka J
    J Clin Gastroenterol; 1981; 3 Suppl 1():47-50. PubMed ID: 7328298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical trial of oral cholecystography using combinations of contrast agents and two consecutive doses.
    Thoeni RF; Moss AA
    Radiology; 1982 Jul; 144(2):271-5. PubMed ID: 7045975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative trial of two oral cholecystographic contrast media--iocetamic acid (Cholebrin) and iopanoic acid (Telepaque).
    Fielding JA; Whitehouse GH
    Clin Radiol; 1979 Jan; 30(1):45-8. PubMed ID: 154372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of fasting on gallbladder opacification during oral cholecystography: a controlled study in normal volunteers.
    Loeb PM; Berk RN; Janes JO; Perkin L; Moore J
    Radiology; 1978 Feb; 126(2):395-401. PubMed ID: 341220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gallbladder density and iodine concentration in humans during oral cholecystography. A comparison of iopanoic acid and iopronic acid.
    Thompson WM; Meyers WC; Shaw M; Bates M; Johnson GA; Hedlund LW
    Invest Radiol; 1982; 17(6):621-8. PubMed ID: 6759456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of fasting on opacification of the gallbladder during oral cholecystography using two consecutive doses in a canine model.
    Thoeni RF; Moss AA; Stoughton JA
    Invest Radiol; 1979; 14(3):228-32. PubMed ID: 468495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugated sodium tyropanoate (Bilopaque) in the bowel: significance of its presence or absence after first-dose oral cholecystography.
    Muhletaler CA; Gerlock AJ; Avant GR
    Radiology; 1981 Nov; 141(2):311-6. PubMed ID: 7291552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new contrast agent for oral cholecystography: iopronic acid (Oravue).
    Pizzolato NF; Arcomano JP; Baum AE
    AJR Am J Roentgenol; 1978 May; 130(5):845-7. PubMed ID: 417581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiographic appearance of the nonabsorbed (unconjugated) and conjugated sodium tyropanoate (Bilopaque) in the bowel.
    Muhletaler CA; Gerlock AJ; Amberg JR; Avant GR
    Invest Radiol; 1982; 17(5):506-9. PubMed ID: 7141832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic technique for acalculous cholecystitis.
    Adams TW; Foxley EG
    Surg Gynecol Obstet; 1976 Feb; 142(2):168-70. PubMed ID: 1246662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose oral cholecystography.
    Krook PM; Bush WH
    Radiology; 1978 Jun; 127(3):643-4. PubMed ID: 663149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of fractionated administration of Telepaque on gallbladder visualization.
    Koehler PR; Kyaw MM
    Radiology; 1973 Sep; 108(3):517-9. PubMed ID: 4723651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.